title: Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.
abstract: The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).
authors.affiliation: World Health Organization, Via Appia 20, CH-1211 Geneva, Switzerland.
authors.forename: David
authors.initials: D
authors.lastname: Fitzsimons
authors.forename: Guido
authors.initials: G
authors.lastname: François
authors.forename: Andrew
authors.initials: A
authors.lastname: Hall
authors.forename: Brian
authors.initials: B
authors.lastname: McMahon
authors.forename: André
authors.initials: A
authors.lastname: Meheus
authors.forename: Alessandro
authors.initials: A
authors.lastname: Zanetti
authors.forename: Bernard
authors.initials: B
authors.lastname: Duval
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Jilg
authors.forename: Wulf Otto
authors.initials: WO
authors.lastname: Böcher
authors.forename: Sheng-Nan
authors.initials: SN
authors.lastname: Lu
authors.forename: Ulus
authors.initials: U
authors.lastname: Akarca
authors.forename: Daniel
authors.initials: D
authors.lastname: Lavanchy
authors.forename: Susan
authors.initials: S
authors.lastname: Goldstein
authors.forename: Jangu
authors.initials: J
authors.lastname: Banatvala
authors.forename: Pierre Van
authors.initials: PV
authors.lastname: Damme
mesh_terms: D004279:DNA, Viral / Q000032:analysis; D006509:Hepatitis B / Q000453:epidemiology / Q000235:genetics / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000032:analysis; D017325:Hepatitis B Vaccines / Q000627:therapeutic use*; D006801:Humans; D017589:Immunization Programs / Q000639:trends*; D007117:Immunization, Secondary / Q000639:trends*; D007156:Immunologic Memory / Q000276:immunology*; D009154:Mutation; D013995:Time
chemical_list: D004279:DNA, Viral; D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines